Literature DB >> 22821114

Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin.

Yoshihiro Kobashi1, Keiji Mouri, Yasushi Obase, Shigeki Kato, Mikio Oka.   

Abstract

A 63-year-old man with a past history of resection of pulmonary adenocarcinoma and COPD visited our hospital because of fever, cough and purulent sputum. Chest CT showed an infiltration shadow with multiple bullae in the right lung. There was a slight elevation of the inflammatory response. We established a definitive diagnosis by frequent isolation of Mycobacterium kyorinense on a sputum culture test of acid-fast bacilli. Clarithromycin and levofloxacin were administered after identification of M. kyorinense using a 16S rRNA gene sequence. Subsequently his symptoms improved following combined therapy with clarithromycin and levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821114     DOI: 10.2169/internalmedicine.51.6431

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement.

Authors:  Tatsuyoshi Ikeue; Hiroshi Yoshida; Eiichiro Tanaka; Issei Ohi; Susumu Noguchi; Akari Fukao; Satoshi Terashita; Sadao Horikawa; Takakazu Sugita
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

3.  Pulmonary Mycobacterium kyorinense infection secondary to cavitary pulmonary tuberculosis.

Authors:  Genta Nagao; Shinichi Okuzumi; Tomoo Kakimoto; Naoto Minematsu
Journal:  IDCases       Date:  2022-03-15

4.  Pulmonary cavitary Mycobacterium kyorinense (M. kyorinense) infection in an Australian woman.

Authors:  Sanjeevan Muruganandan; Lata Jayaram; Jenny Siaw Jin Wong; Stephen Guy
Journal:  IDCases       Date:  2015-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.